TrueBlue, Inc. (TBI) P/E Ratio History
Historical price-to-earnings valuation from 1997 to 2023
Loading P/E history...
TBI Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, TrueBlue, Inc. (TBI) trades at a price-to-earnings ratio of -3.7x, with a stock price of $6.01 and trailing twelve-month earnings per share of $-1.77.
The current P/E is 121% below its 5-year average of 18.0x. Over the past five years, TBI's P/E has ranged from a low of 8.3x to a high of 48.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Industrials sector median P/E of 25.5x, TBI trades at a 115% discount to its sector peers. The sector includes 413 companies with P/E ratios ranging from 0.0x to 185.3x.
Relative to the broader market, TBI trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TBI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
TBI P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $3B | 14.6 | 0.75 | +42% | |
| $1B | 143.9 | - | -84% | |
| $895M | 8.1 | - | -32% | |
| $790M | 22.1 | - | -25% | |
| $2B | 6.1Lowest | 0.13Best | +180%Best | |
| $86B | 21.5 | 1.81 | +10% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
TBI Historical P/E Data (1997–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q2 | Sun Jun 25 2023 00:00:00 GM | $17.69 | $0.47 | 37.6x | +24% |
| FY2023 Q1 | Sun Mar 26 2023 00:00:00 GM | $17.08 | $1.43 | 11.9x | -61% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $19.58 | $1.86 | 10.5x | -65% |
| FY2022 Q3 | Sun Sep 25 2022 00:00:00 GM | $19.51 | $2.22 | 8.8x | -71% |
| FY2022 Q2 | Sun Jun 26 2022 00:00:00 GM | $17.65 | $2.12 | 8.3x | -73% |
| FY2022 Q1 | Sun Mar 27 2022 00:00:00 GM | $29.38 | $1.85 | 15.9x | -48% |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $27.67 | $1.75 | 15.8x | -48% |
| FY2021 Q3 | Sun Sep 26 2021 00:00:00 GM | $28.00 | $1.41 | 19.9x | -35% |
| FY2021 Q2 | Sun Jun 27 2021 00:00:00 GM | $29.52 | $1.13 | 26.1x | -14% |
| FY2021 Q1 | Sun Mar 28 2021 00:00:00 GM | $21.81 | $0.45 | 48.5x | +60% |
| FY2019 Q4 | $24.06 | $1.61 | 14.9x | -51% | |
| FY2019 Q3 | Sun Sep 29 2019 00:00:00 GM | $21.10 | $1.75 | 12.1x | -60% |
Average P/E for displayed period: 30.3x
See TBI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TBI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TBI vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonTBI — Frequently Asked Questions
Quick answers to the most common questions about buying TBI stock.
Is TBI stock overvalued or undervalued?
TBI trades at -3.7x P/E, below its 5-year average of 18.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does TBI's valuation compare to peers?
TrueBlue, Inc. P/E of -3.7x compares to sector median of 25.5x. The discount suggests lower growth expectations or higher risk.
What is TBI's PEG ratio?
TBI PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1997-2023.